医学
乳腺癌
人口
癌症
危险系数
队列
内科学
癌症登记处
共病
比例危险模型
队列研究
全国死亡指数
肿瘤科
置信区间
环境卫生
作者
Alzina Koric,Chun‐Pin Chang,Bayarmaa Mark,Kerry Rowe,John Snyder,Mark K. Dodson,Vikrant Deshmukh,Michael G. Newman,Alison Fraser,Ken R. Smith,Ankita Date,Lisa H. Gren,Christina A. Porucznik,Benjamin Haaland,Norah Lynn Henry,Mia Hashibe
出处
期刊:Cancer
[Wiley]
日期:2022-05-13
卷期号:128 (14): 2826-2835
被引量:2
摘要
Breast cancer survival is increasing, making late effects such as cardiovascular disease (CVD) more relevant. The purpose of this study was to evaluate incident CVD following breast cancer diagnosis among long-term survivors and to investigate possible risk factors for CVD.A population-based cohort of 6641 breast cancer survivors diagnosed between 1997 and 2009 who survived at least 10 years was identified within the Utah Cancer Registry. In addition, 36,612 cancer-free women from the general population, matched by birth year and state, were identified within the Utah Population Database. Cox proportional hazards models were used to calculate CVD hazard ratios (HRs) for >10 to 15 and >15 years.Long-term breast cancer survivors had an increased risk of newly diagnosed diseases of the circulatory system (HR, 1.32; 99% confidence interval [CI], 1.00-1.75) from 10 to 15 years following cancer diagnosis compared with the general population. No increased CVD risks were observed after 15 years. Breast cancer survivors with Charlson Comorbidity Index score ≥2 had a significantly higher risk of diseases of the circulatory system (HR, 2.64; 95% CI, 1.08-6.45) beyond 10 years following breast cancer diagnosis. Similarly, older age, obesity, lower education, and family history of CVD and breast cancer were risk factors for heart and circulatory system diseases among long-term breast cancer survivors.Risk of CVD compared to the general population was moderate among this cohort of long-term breast cancer survivors between 10 to 15 years since cancer diagnosis. Awareness of CVD risks is important for breast cancer survivors.
科研通智能强力驱动
Strongly Powered by AbleSci AI